Drug Type Small molecule drug |
Synonyms Compound Trizin and Rutinum, Hydrochlorothiazide/Dihydralazine Sulfate/Promethazine Hydrochloride/Rutin/Chloroquine phosphate/Potassium Chloride/Vitamin B6/V/itamin B1/Reserpine/Magnesium Trisilicate, 复方三嗪芦丁 |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists), NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors), VMAT1 antagonists(solute carrier family 18 member A1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC18H29ClN3O4P |
InChIKeyAEUAEICGCMSYCQ-UHFFFAOYSA-N |
CAS Registry50-63-5 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | CN | - | - |